CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands		Dec. 31, 2020	Dec. 31, 2019
Current assets
Cash and cash equivalents		$ 193,470	$ 103,189
Restricted cash		0	75
Investment in marketable securities		67,695	116,539
Receivables, net		7,058	11,004
Receivables, net – related parties		49,260	48,136
Other receivables		4,297	16,885
Prepaid expenses and other current assets		16,747	10,315
Loan receivable - short term		50	22,925
Total current assets		338,577	329,068
Noncurrent assets
Land, property and equipment, net		29,890	12,130
Intangible assets, net		86,985	103,012
Goodwill		239,053	238,505
Loans receivable		480	0
Loans receivable – related parties		4,145	0
Investments in other entities – equity method		43,292	28,427
Investments in privately held entities		37,075	896
Restricted cash		500	746
Operating lease right-of-use assets		18,574	14,248
Other assets		18,915	1,681
Total noncurrent assets		478,909	399,645
Total assets	[1]	817,486	728,713
Current liabilities
Accounts payable and accrued expenses		36,143	27,279
Fiduciary accounts payable		9,642	2,027
Medical liabilities		50,330	58,725
Income taxes payable		4,224	4,529
Dividend payable		485	271
Finance lease liabilities		102	102
Operating lease liabilities		3,177	2,991
Current portion of long-term debt		10,889	9,500
Total current liabilities		114,992	105,424
Noncurrent liabilities
Deferred tax liability		10,959	18,269
Finance lease liabilities, net of current portion		311	415
Operating lease liabilities, net of current portion		15,865	11,373
Long-term debt, net of current portion and deferred financing costs		230,211	232,172
Total noncurrent liabilities		257,346	262,229
Total liabilities	[1]	372,338	367,653
Commitments and Contingencies (Note 13)
Mezzanine equity
Noncontrolling interest in Allied Physicians of California, a Professional Medical Corporation ("APC")		114,237	168,725
Stockholders’ equity
Common stock, par value $0.001; 100,000,000 shares authorized, 42,249,137 and 35,908,057 shares outstanding, excluding 12,323,164 and 17,458,810 treasury shares, at December 31, 2020 and 2019, respectively		42	36
Additional paid-in capital		261,011	159,608
Retained earnings		69,771	31,905
Stockholders' equity attributable to parent		330,824	191,549
Noncontrolling interest		87	786
Total stockholders’ equity		330,911	192,335
Total liabilities, mezzanine equity and stockholders’ equity		817,486	728,713
Series A Preferred stock, par value $0.001; 5,000,000 shares authorized (inclusive of Series B Preferred stock); 1,111,111 issued and zero outstanding
Stockholders’ equity
Preferred stock		0	0
Series B Preferred stock, par value $0.001; 5,000,000 shares authorized (inclusive of Series A Preferred stock); 555,555 issued and zero outstanding
Stockholders’ equity
Preferred stock		$ 0	$ 0

[1] The Company's consolidated balance sheets include the assets and liabilities of its consolidated variable interest entities ("VIEs"). The consolidated balance sheets include total assets that can be used only to settle obligations of the Company’s consolidated VIEs totaling $801.3 million and $849.3 million as of December 31, 2020 and December 31, 2019, respectively, and total liabilities of the Company’s consolidated VIEs for which creditors do not have recourse to the general credit of the primary beneficiary of $111.3 million and $114.5 million as of December 31, 2020 and December 31, 2019, respectively. See Note 18 – Variable Interest Entities (VIEs) for further detail.